热门资讯> 正文

Insight分子诊断公司2025年第四季度盈利预览

2026-03-26 05:35

Insight Molecular Diagnostics Inc.(IMDX) 0

Insight Molecular Diagnostics Inc. (IMDX) is scheduled to announce Q4 earnings results on Thursday, March 26th, after market close.
The consensus EPS estimate is -$0.24, and the consensus revenue estimate is $0.28M (-81.2% Y/Y).
Over the last 1 year, IMDX has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.

More on Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics prices $26M registered direct offering; shares down
Seeking Alpha’s Quant Rating on Insight Molecular Diagnostics Inc.
Historical earnings data for Insight Molecular Diagnostics Inc.
Financial information for Insight Molecular Diagnostics Inc.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。